Lhc Group Inc (LHCG) Return on Equity ROE from the fourth quarter 2022 to fourth quarter 2021 and annually, average high and low, overall ranking from Dec 31 2022 to Dec 31 2021 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Lhc Group Inc   (NASDAQ: LHCG)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare

Lhc Group Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Lhc Group Inc in the fourth quarter 2022?
Lhc Group Inc achieved a return on average equity (ROE) of 3.61 % in its fourth quarter 2022, which is below Lhc Group Inc 's average return on equity, which stands at 9.62%.

ROE decreased relative to the period ending , due to the decline in net income.

Within the Healthcare Facilities industry 21 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the third quarter 2022 from 1863 to 2382.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter
Y / Y Equity Change 1.71 % -1.79 % -1.33 % 0.19 % -
Y / Y Net Income Change - -34.99 % -68.04 % -39.71 % -43.18 %
Net Income (TTM) in Millions 60 84 95 127 144
Return On Equity (TTM) 3.61 % 5.02 % 5.71 % 7.59 % 8.58 %
LHCG's Total Ranking # 2382 # 1863 # 2071 # 1935 # 1934
Equity (TTM) in Millions 1,680 1,686 1,662 1,648 1,652
Seq. Equity Change -0.31 % 1.4 % 0.88 % -0.26 % -3.73 %
Seq. Net Income Change - 47.32 % -40.18 % 15.8 % -36.3 %

Back to LHCG Management Effectiveness >> LHCG's 5 Years Annual ROE >> Compare LHCG ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 22
Sector # 184
Overall # 2382

Return On Equity Statistics
High Average Low
13 %
9.62 %
3.61 %
(Dec 31 2017)   (Dec 31 2022)





LHCG Annual Return On Equity (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018
Total Equity in Millions 1,680 1,652 1,613 1,507 1,424
Y / Y Equity Change 1.71 % 2.4 % 7.04 % 5.81 % 181.19 %
Net Income in Millions 60 144 138 114 79
Y / Y Net Income Change -58.05 % 4.12 % 21.15 % 44.26 % 30.7 %
Return On Equity 3.59 % 8.69 % 8.55 % 7.55 % 5.54 %

Back to LHCG Management Effectiveness >> LHCG's 5 Years Annual ROE >> Compare LHCG ROE to its Competitors




Annual Roe Comment
In 2022 ROE decreased compared to the previous year to 3.59 %, due to deterioration of net income.


More Return On Equity Ratios
Healthcare Facilities Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
LHCG's' Return on Equity at Yahoo Finance
LHCG's Roe Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for LHCG's Competitors
Subscribers only: Roe for Lhc Group Inc 's Suppliers
Subscribers only: Return On Equity for LHCG's Customers




Companies with similar Return On Equity at Dec 31 2022, within Healthcare Sector ROE
The Oncology Institute Inc   9.54 %
Celularity Inc   9.41 %
Teleflex Incorporated  9.33 %
Progyny Inc   9.24 %
Astrazeneca Plc  8.89 %
Fonar Corporation  8.45 %
Orasure Technologies Inc  8.27 %
Incyte Corporation  8.24 %
Healthcare Services Group Inc   8.03 %
Syneos Health Inc   7.91 %
Lemaitre Vascular Inc   7.90 %
Precision Optics Corporation Inc   7.89 %
Oncotelic Therapeutics Inc   7.81 %
Medtronic Plc  7.77 %
Pediatrix Medical Group Inc   7.64 %
Addus Homecare Corp  7.56 %
Radnet Inc   7.38 %
Supernus Pharmaceuticals inc   7.12 %
Merit Medical Systems Inc  6.83 %
Pharming Group N v   6.68 %
Viemed Healthcare Inc   6.54 %
Medicure Inc   6.50 %
Becton Dickinson And Company  6.40 %
American Shared Hospital Services  6.15 %
Electromed Inc   6.11 %
Organogenesis Holdings Inc   6.09 %
The Pennant Group Inc   6.01 %
Envista Holdings Corporation  6.00 %
Icon Plc  5.93 %
Fresenius Medical Care Ag  5.79 %

Date modified: 2026-09-08T15:10:49+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.